Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies? | J Neuromuscul Dis | 2022 | 35848034 | PubTator, text mining | PubMed |
| Structural Context of a Critical Exon of Spinal Muscular Atrophy Gene. | Front Mol Biosci | 2022 | 35847983 | PubTator, text mining | PubMed |
| PRKRAP1 and Other Pseudogenes in Movement Disorders: The Troublemakers in Genetic Analyses Are More Than Genomic Fossils. | Mov Disord Clin Pract | 2022 | 35844281 | PubTator, text mining | PubMed |
| Early treatment is a lifeline for infants with SMA. | Nat Med | 2022 | 35840728 | PubTator, text mining | PubMed |
| Newborn Screening for Spinal Muscular Atrophy in New York State: Clinical Outcomes From the First 3 Years. | Neurology | 2022 | 35835557 | PubTator, text mining | PubMed |
| Biochemical and clinical biomarkers in adult SMA 3-4 patients treated with nusinersen for 22 months. | Ann Clin Transl Neurol | 2022 | 35833245 | PubTator, text mining | PubMed |
| Peripheral circulation disturbances in two consecutive children with spinal muscular atrophy and literature review. | Acta Myol | 2022 | 35832505 | PubTator, text mining | PubMed |
| Muscle quantitative MRI in adult SMA patients on nusinersen treatment: a longitudinal study. | Acta Myol | 2022 | 35832502 | PubTator, text mining | PubMed |
| Biotransformation novel advances - 2021 year in review. | Drug Metab Rev | 2022 | 35815654 | PubTator, text mining | PubMed |
| HDAC4 Inhibitors as Antivascular Senescence Therapeutics. | Oxid Med Cell Longev | 2022 | 35814270 | PubTator, text mining | PubMed |
| Next RNA Therapeutics: The Mine of Non-Coding. | Int J Mol Sci | 2022 | 35806476 | PubTator, text mining | PubMed |
| Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson's disease-associated GBA gene. | Commun Biol | 2022 | 35794204 | PubTator, text mining | PubMed |
| R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy. | Front Cell Neurosci | 2022 | 35783101 | PubTator, text mining | PubMed |
| Secondary structures in RNA synthesis, splicing and translation. | Comput Struct Biotechnol J | 2022 | 35765654 | PubTator, text mining | PubMed |
| Engineered U1 snRNAs to modulate alternatively spliced exons. | Methods | 2022 | 35764245 | PubTator, text mining | PubMed |
| Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial. | J Neurol | 2022 | 35763114 | PubTator, text mining | PubMed |
| Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis. | BMC Med | 2022 | 35754054 | PubTator, text mining | PubMed |
| Targeted Degradation of mRNA Decapping Enzyme DcpS by a VHL-Recruiting PROTAC. | ACS Chem Biol | 2022 | 35749470 | PubTator, text mining | PubMed |
| Physical Therapy and Nusinersen Impact on Spinal Muscular Atrophy Rehabilitative Outcome. | Front Biosci (Landmark Ed) | 2022 | 35748255 | PubTator, text mining | PubMed |
| Genetic Profile of Patients with Limb-Girdle Muscle Weakness in the Chilean Population. | Genes (Basel) | 2022 | 35741838 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=46